Delivery Order SPE2DE24D0013-SPE2D625F8F3H

The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on May 19, 2025, with completion targeted for May 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious disease testing capabilities aligned with federal pandemic preparedness and ongoing surveillance needs. The order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. This award represents a discrete purchase drawn from Cepheid's existing indefinite delivery vehicle contracts, which provide the company with established procurement vehicles for continuous supply of molecular diagnostic reagents and assays to federal healthcare systems.

Cepheid, a recognized leader in molecular diagnostics based in Sunnyvale, California, maintains an established track record supplying diagnostic testing solutions across the federal government, including the Veterans Affairs system and Defense Logistics Agency. The company's GeneXpert diagnostic systems and associated test kits have been instrumental in supporting federal infectious disease detection programs. This delivery order reflects Cepheid's competitive positioning within the federal molecular diagnostics market and supports the Defense Department's medical supply chain requirements for rapid infectious disease identification and response capabilities.